General Information of the Compound
Compound ID
CP0412324
Compound Name
4-(4-benzylpiperazin-1-yl)-5-bromo-1H-pyridazin-6-one
    Show/Hide
Structure
Formula
C15H17BrN4O
Molecular Weight
349.232
Canonical SMILES
Brc1c(cn[nH]c1=O)N1CCN(Cc2ccccc2)CC1
    Show/Hide
InChI
InChI=1S/C15H17BrN4O/c16-14-13(10-17-18-15(14)21)20-8-6-19(7-9-20)11-12-4-2-1-3-5-12/h1-5,10H,6-9,11H2,(H,18,21)
    Show/Hide
InChIKey
JYMQNTALXSHRLU-UHFFFAOYSA-N
Physicochemical Property
logP
1.8546
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
52.23
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 133638366
ChEMBL ID
CHEMBL4524687
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05452, Short transient receptor potential channel 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 18000 nM
   TI
   LI
   LO
   TS